Top compounds associated with response to BMI1


Feature Type Standardized
Nominal ANOVA
mRNA narciclasine CTRPv2 pan-cancer AAC -0.056 0.1
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA tivozanib CTRPv2 pan-cancer AAC -0.061 0.1
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.058 0.1
mRNA PF-3758309 CTRPv2 pan-cancer AAC 0.071 0.1
mRNA VU0155056 CTRPv2 pan-cancer AAC 0.062 0.1
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.059 0.1
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA masitinib CTRPv2 pan-cancer AAC -0.059 0.1
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.057 0.1
Download CSV